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Adenosine, deoxyadenosine, and deoxycytidine can be phosphorylated 
to their respective nucleoside 5’-monophosphates by kinase enzymes. In 
addition to their physiological role of salvaging nucleosides to form nu- 
cleotides, these enzymes are critical for the increased intracellular con- 
centration of dATP associated with a deficiency of adenosine deaminase 
(1,2). These enzymes also phosphorylate nucleoside analogs that have 
antineoplastic or antiviral properties. 
The development of relatively simple assays, using high specific activity 
isotopes and anion exchange paper (3) has allowed extensive investigation 
of nucleoside kinases. During our studies of placental nucleoside kinases 
we used previously developed assay conditions (3-5) including uniformly 
labeled substrates (6-8). However, we could not achieve linearity with 
time or protein. 
To develop valid methods for these assays, we had to systematically 
investigate specific problems related to the measurement of adenosine 
kinase (ATP: adenosine 5’-phosphotransferase, EC2.7.1.20), deoxyaden- 
osine kinase (ATP: deoxyadenosine 5’-phosphotransferase EC2.7.1.76), 
and deoxycytidine kinase (NTP: deoxycytidine 5’-phosphotransferase, 
EC2.7.1.74) in placental cytosol. Our observations suggest the following 
conditions are important for the assay of kinase enzymes in crude prep- 
arations: (a) the addition of potassium cation for deoxyadenosine and 
adenosine kinases, (b) the addition of a sulfhydryl reducing reagent, and 
(c) the substitution of GTP for ATP as the phosphate donor for deoxy- 
adenosine kinase and adenosine kinase. Our observations also confirm 
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that deaminase inhibitors are essential to prevent substrate degradation 
(9-15). 
MATERIALS AND METHODS 
Materiuls 
The following reagents were obtained from Sigma Chemical Company. 
St. Louis, Missouri: Bials reagent, Trizma Base, P-mercaptoethanol, 
dithiothreitol, adenosine, deoxyadenosine, deoxycytidine. adenosine 5’- 
triphosphate, guanosine 5’-triphosphate, bovine serum albumin, deoxy- 
ribose l-phosphate and deoxyribose 5-phosphate. The following were 
obtained from Amersham Corporation, Arlington Heights, Illinois: [S- 
14C]ATP (1.03 mCi/mmole). [U-‘4C]deoxyadenosine (536 mCi/mmole). 
[U-‘4C]deoxycytidine (462 mCi/mmole). and ACS scintillation cocktail. 
From ICN Pharmaceuticals, Inc., Irvine, California, [S-‘Hldeoxyadenosine 
t 15 Ci/mmole) and [5-3H]deoxycytidine (25 Ciimmole) were obtained. 
New England Nuclear, Boston, Massachusetts was the source for 
]8-‘4C]adenosine (54 or 45 mCi/mmole). Tetrahydrouridine, a cytidine 
deaminase inhibitor. was obtained from Calbiochem-Behring, La Jolla. 
California. DE-81 ion exchange disks and Whatman 3MM chromatography 
paper were purchased from Fisher Scientific Company, Fair Lawn, New 
Jersey. Bio-Rad protein dye reagent concentrate was obtained from Bio- 
Rad Laboratories, Richmond, California. Erythro-9-(2-hydroxyl-3- 
nonyl)adenine (EHNA), an adenosine deaminase inhibitor, was purchased 
from Burroughs Wellcome Company, Research Triangle Park, North 
Carolina. The drug 2’-deoxycoformycin, another adenosine deaminase 
inhibitor, was a gift from Warner LambertiParker Davis. Ann Arbor. 
Michigan. All other reagents were of the highest quality generally 
obtainable. 
Placenta Prepuration 
Human placentae were processed within 8 hr of delivery. Prior to 
processing the placenta1 membranes were discarded and the remaining 
tissue was blotted on gauze, weighed, and then coursely minced. The 
minced tissue was suspended in 10 mM /3-mercaptoethanol and 10 mM 
imidazole-HCl, pH 7.0 (1 g tissue/4.3 ml) and then homogenized using 
a Sorval Omni-mixer at maximum speed for four periods of 30 set each. 
The homogenate was spun at 28,000g for 1 hr at 4°C in a Sorval refrigerated 
centrifuge and the resulting supernatant was stored at -70°C. This extract 
was usually dialyzed for 16 hr against 10 mM @mercaptoethanol and 10 
mM Tris-HCI, pH 7.0, prior to enzyme assay. 
Separution Methods 
A number of methods were used to separate substrates and products 
of the reactions. Nucleosides were separated from nucleotides by spotting 
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207.~1 ahquots of incubation extracts onto DE-81 disks (3) or onto Whatman 
3MM chromatography sheets. The chromatography sheets were also 
spotted with authentic nucleoside substrate and nucleotide product (1 
mg/ml). The disks were washed twice for 5 min with 1 mM ammonium 
formate, and subsequently washed twice with water and once with 95% 
ethanol. With tritiated isotopes the disks were placed into scintillation 
vials with 0.5 ml of 0.1 N HCl and 0.4 M KC1 to elute the radioactive 
nucleotide products (3) and were counted in 5 ml A.CS. High voltage 
electrophoresis was performed with either 50 mM sodium borate, pH 8.9, 
or 50 mM sodium citrate, pH 3.5. High voltage electrophoresis in borate 
buffer was run at 4000 Volts and 250 mA for 30 min or in citrate buffer 
at 2000 Volts and 100 mA for 60 min. The carrier compounds were 
located using an ultraviolet light. The migration of relevant compounds 
was determined in these two buffer systems (Table 1). The spots were 
cut out and counted in a liquid scintillation spectrometer system. 
Radioactive deoxyribose- l-phosphate was separated from purine or 
pyrimidine compounds in the heat-inactivated reaction mixtures by the 
addition of an equal volume of a 10% charcoal solution. Deoxyribose- 
l-phosphate does not bind to charcoal and remains in the supernatant, 
while all purine and pyrimidine compounds are removed by the charcoal. 
Ribose- or deoxyribose-containing compounds were detected by using a 
spray containing Bials reagent (0.9% ferric chloride and 0.55% orcinol 
in acidified ethanol). 
TABLE 1 
RELATIVE MIGRATION OF NUCLEOSIDES AND NUCLEOTIDES ON HIGH VOLTAGE 
ELECTROPHORESIS 
Centimeters migrated 
Compound Sodium borate” Sodium citrate6 
Adenosine 9 











” 50 mM Sodium borate, pH 8.9, run at 4000 V and 250 mA for 20 min. 
’ 50 mM Sodium citrate, pH 3.5, run at 2000 V and 100 mA for 60 min. 















Assay conditions were devised to give linearity with time and protein. 
The final conditions used represent a combination of our previous work 
(4.5). the reports of others (9-15) and our current observations. Adenosine 
kinase and deoxyadenosine kinase were assayed as follows: 50 mM Tris- 
HCI, pH 7.4. 1.2 mM GTP, 1.6 mM MgCl:. 50 mM KCl. 50 mM /3-mer- 
captoethanol, 1 mg/ml bovine serum albumen, 50 PM EHNA. and 10 PM 
[8-‘4C]adenosine or 500 PM [8-3H]deoxyadenosine in a total volume of 
50 ~1. Deoxycytidine kinase was assayed as follows: 50 mM Tris-HCI 
pH 8.0, 2.0 mM ATP, 2.4 mM MgCl:, 25 mM dithiothreitol. 125 FM te- 
trahydrouridine, 1 mgiml bovine serum albumen. and IO ELM [5- 
3H]deoxycytidine in a total volume of 50 ~1. Adjustments of other com- 
ponents of the assays are described under results. The following incubation 
periods at 37°C were used: deoxyadenosine kinase. 20 min: deoxycytidine 
kinase, 20 min; adenosine kinase, 5 min. The assays were stopped by 
heat inactivation at 85°C for 2 min. Isolation of nucieotide product was 
performed using DE-81 disks as described above. The formation of specific 
nucleotide product was confirmed using comigration with the authentic 
compound during high voltage electrophoresis. Comigration with the 
nucleoside di- and triphosphate derivatives was also examined. The assays 
were linear with time and protein. 
The formation of adenosine from ATP degradation during the assay\ 
of adenosine kinase or deoxyadenosine kinase was measured in two 
ways. In one series of studies, 1.2 mM [8-‘4CJATP was used and the 
formation of [ 8-‘4C]adenosine was measured after its separation with high 
voltage electrophoresis in borate buffer. In another series of studies no 
isotope was used and adenosine formation from ATP was measured by 
high-pressure liquid chromatography using a Waters FBondapak C ,x column 
and isocratic elution of adenosine by 50 mM ammonium phosphate, pH 
6.0. in 5% methanol. Using a flow rate of 2 mlimin adenosine eluted at 
I5 min. 
Protein was estimated using the Bio-Rad assay method with bovine 
serum albumin as the standard protein (16). 
RESULTS 
Deaminase Inhihitioll 
In our initial assays of deoxyadenosine kinase and deoxycytidine kinase. 
we followed previously published procedures (3-8). These conditions 
included the following: ATP as phosphate donor, no addition of potassium 
or sulfhydryl reducing compound, 500 PM [U-‘4C]deoxyadenosine or 
[U-‘4C]deoxycytidine. and DE-81 disks for product isolation. With these 
assay conditions we were unable to establish linearity with time and 
protein for deoxyadenosine kinase or deoxycytidine kinase. Furthermore. 
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the addition of 50 FM EHNA or deoxycoformycin caused apparent inhibition 
of deoxyadenosine kinase. This was puzzling because previous studies 
had indicated the importance of blocking adenosine deaminase or cytidine 
deaminase during the measurement of kinase activity in order to prevent 
substrate degradation (9-1.5). With the uniformly labeled substrates we 
were able to demonstrate that half of the product being measured with 
the initial assay conditions was deoxyribose-l-phosphate (Table 2). This 
latter compound behaved exactly like a nucleotide on the DE-81 disks 
or during high voltage electrophoresis, which was confirmed by using 
authentic deoxyribose-l-phosphate. The radioactively labeled deoxyribose- 
l-phosphate was distinguished from radioactivity labeled purines or py- 
rimidines by its property of not binding to charcoal. Deoxyribose-l- 
phosphate remained in the supernatant following charcoal extraction of 
reaction mixtures. The increased formation of nucleotide product and 
the decreased synthesis of deoxyribose-l-phosphate was evident in the 
assay of deoxyadenosine kinase under conditions which optimize the 
assay method (Table 2). In a similar study with deoxycytidine kinase, 
we observed 2.4 nmole deoxyribose-l-phosphate and 0.2 nmole nucleotide 
formed after a 30-min incubation period using initial assay conditions 
plus 50 mM @mercaptoethanol. This problem was similarly modified using 
the optimized conditions described below. 
The source of inorganic phosphate to serve as substrate for the phos- 
phorolysis reactions in dialyzed placental cytosol was initially unclear. 
However, when we calculated the amount of inorganic phosphate generated 
from the dephosphorylation of triphosphate substrate, we found that 
there was a sufficient amount to permit these reactions. 
TABLE 2 
FORMATION OF DEOXYRIBOSE-I-PHOSPHATE DURING ASSAY OF DEOXYADENOSINE KINASE 
Additions to assay 
Albumin (bovine 
serum, 1 mgiml). 
KCI (50 mM). p- 
mercaptoethanol Deoxycoformycin Deoxyribose- l- Nucleotide 
(50 rnM) (50 /AM) phosphate” product” 
- - 0.16 0.14 
+ - 0.14 0.15 
- + 0 0.12 
+ + 0.05 0.11 
+ + 0.06 0.40” 
NOW. All assays contained 0.2 mg placental protein extract, 1.2 mM ATP, 1.6 mM MgCI,, 
50 mM Tris-HCI, pH 7.4, and 500 PM [U-‘4Cldeoxyadenosine and were incubated at 37°C 
for 30 min. 
” 1.2 mM GTP was substituted for I.2 mM ATP. 
’ nmoli50~1 reaction mixture. 
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FIG. I. Metabolic interconversions of deoxyadenosine and deoxycytidine. (AI Deoxy- 
adenosine is deaminated to deoxyinosine (reaction 3). Both compounds may be phosphorylated 
(reactions I and 2). Deoxyinosine undergoes phosphorolysis to hypoxanthine and deoxyribose- 
i-phosphate (reaction 4). (B) Deoxycytidine is deaminated to deoxyuridine (reaction 7). 
Both compounds may be phosphorylated (reactions 5 and 6). Deoxyuridine undergoes 
phosphorolysis to deoxyribose-l-phosphate and uracil (reaction 8). With uniformly labeled 
isotopes all these intermediates are radioactively labeled. 
The extensive substrate deamination observed, together with the sub- 
sequent phosphorolysis or phosphorylation of the resulting degradation 
products (Fig. I), emphasizes that product identification is essential. For 
example, in the deoxycytidine kinase assay, all the deoxcytidine is deam- 
inated to deoxyuridine and deoxyuridine kinase was actually measured 
unless cytidine deaminase was inhibited (Table 31. The addition of an 
adenosine deaminase inhibitor was also important in protecting against 
the degradation of deoxyadenosine to deoxyinosine (Table 4). In addition, 
TABLE .3 









I pmole I 
Deoxycytidine Deoxyuridine 
IX 103x 




Note. Placental cytosol was preincubated for 60 min with tetrahydrouridine. Placental 
cytosol (40 pg protein) was then incubated with 20 WM [S-‘H]deoxycytidine. 100 rnM Tris- 
HCI, pH 8.0. IO mM ATP. I2 mM MgCI:, 12.5 mM dithiothreitol, and I mgiml bovine serum 
albumin for 30 min. The compounds were separated by high voltage electrophoresis in 50 
mM sodium citrate pH 3.5. 
” pmole/50 ~1 reaction mixture. 
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TABLE 4 
INHIBITION OF DEOXYADENOSINE DEAMINATION BY EHNA IN PLACENTAL SUPERNATANT 
______ 
Compounds recovered (nmole)” 
EHNA” -- _~ ~- 
(PM) Deoxyinosine’ Deoxyadenosine’ 
-.- 
0. 8 14 
0.05 9 17 
0.50 4 20 
5.00 0.6 25 
50.00 0 25 
~. __~ ~- 
” EHNA. erythro-9-(2-hydroxyl-3-nonylladenine. 
li nmolei50 ~1 reaction mixture. 
’ Assays were performed with 400 pg placental supernatant. I .2 mM ATP, I .6 mM MgCl:, 
0.5 mM [LJ-‘Qdeoxyadenosine. and 50 mM Tris-HCI, pH 7.4. 
our studies in placental cytosol revealed that the major product formed 
under valid assay conditions was frequently the nucleoside triphosphate, 
an occurance also previously reported (11). 
These observations support the importance of blocking nucleoside sub- 
strate degradation by deaminase inhibitors as has been done by a number 
of investigators (9-15). 
Phosphate Donor 
The degradation of the phosphate donor substrate has been observed 
by some investigators, who have used ATP regeneration systems for 
assays of crude extracts (9,14,17-22). While we have observed some 
degradation of ATP, the ATP concentration remained saturating. 
In our experiments GTP was substituted for ATP. GTP is as efficient 
as ATP in phosphorylating certain nucleosides (8,23,24). Both adenosine 
kinase and deoxyadenosine kinase exhibited more than a twofold increase 
in activity following the substitution of GTP (Fig. 2. Table 5). Two 
mechanisms could account for this observation: (a) ATP is degraded to 
adenosine, which then inhibits enzyme activity, or (b) GTP is a preferred 
phosphate donor. 
Under optimized conditions of the adenosine kinase assay no adenosine 
accumulation from ATP was detected using [8-‘4C]adenosine release from 
[8-‘4C]ATP or high-pressure liquid chromatography. This supports the 
mechanism (b) above, which agrees with our observations and other 
studies (22,25,26) in highly purified adenosine kinase. 
In contrast, the optimized conditions of the deoxyadenosine kinase 
assay yielded a 2 to 3 FM accumulation of adenosine from ATP. In order 
to assess the effect of adenosine on the deoxyadenosine kinase reaction, 
up to 10 PM adenosine was added to the assay. Ten micromolar adenosine 





FIG. ?. Time course of deoxyadenosine kinase activity in human placental supernatant. 
Protein extract (200 pg) was incubated with 50 mM Tris-HCI, pH 7.4. 50 mM KCI, 50 mM 
P-mercaptoethanol, 1 mgiml bovine serum albumen. 50 PM deoxycoformycin, and 1.2 mM 
ATP or GTP in a total volume of 50 ~1 at 37°C. Under these conditions linearity with time 
is evident up to 20 min with GTP as phosphate donor. 
inhibited deoxyadenosine kinase activity by 60%. However, by adding 
10 PM [8-‘4C]adenosine to the deoxyadenosine kinase reaction mixture, 
it was shown that all the adenosine disappeared and was converted to 
nucleotide at the end of the assay period. It appears that a substantial 
amount of ATP degradation to adenosine must occur during the deoxy- 
adenosine kinase assay to result in the 2 to 3 PM adenosine observed at 
the end of the incubation period. These data support the concept that 
ATP degradation to adenosine inhibits deoxyadenosine kinase during its 
assay in placental cytosol. This proposal was supported by our observation 
that in partially purified enzyme preparations ATP is only slightly superior 
to GTP as a phosphate donor for deoxyadenosine kinase. 
Substitution of GTP for ATP was not useful for deoxycytidine kinase. 
since this decreased its activity in placental cytosol by about 50%. 
TABLE 5 
COMPARISON OF ATP AND GTP AS PHOSPHATE DONORS FOR ADENOSINE KINASE IN H[IMAN 
PLACENTAL CYTOSOL 
Phosphate 
Enzyme specific activity (nmolelhrimg) 
.-- ~-- ._.- 
donor No inhibitor deoxycoformycin (50 @M) 
___~ ___ -- .--~-~~ .~. ._ 
ATP ?9 33 
GTP 59 7-l 
~_.___~~_ 
Note. Placental cytosol (10 pg) was incubated with 10 ~,LM [S-“Cladenosine, I .2 mM ATP 
or GTP, 1.6 mM MgQ. 1 mg/ml bovine serum albumen. 50 mM /3-mercaptoethanol. and 
50 mM KCI for 5 min at 37°C. 
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Monovalent Cation 
The addition of a monovalent cation is important for the measurement 
of adenosine kinase, while potassium is an absolute requirement for the 
measurement of deoxyadenosine kinase (Table 6). In the adenosine kinase 
assay sodium appeared equally capable of activating the reaction and 
lithium was more effective than either potassium or sodium. In the deoxy- 
adenosine assay neither sodium nor lithium could activate the enzyme. 
Deoxycytidine kinase activity was not altered by monovalent cations 
(Table 6). 
Thiol Reagents 
The addition of either fi-mercaptoethanol or dithiothreitol is critical 
for the deoxycytidine kinase assay. In fact, unless tissue extracts were 
prepared with 10 mM P-mercaptoethanol, no deoxycytidine kinase could 
be measured. This is in accord with previous observations (12). 
The activity of adenosine kinase and deoxyadenosine kinase was en- 
hanced by j?-mercaptoethanol (Table 7). We routinely prepare our placental 
cytosol with 10 mM /3-mercaptoethanol, since it is essential for the stability 
of deoxycytidine kinase and does not change the stability of adenosine 
or deoxyadenosine kinase. 
DISCUSSION 
The assays of nucleoside kinases have attracted attention recently 
because these enzymes have an important relationship to enzyme defi- 
TABLE 6 







0 0.4 27 0 
2 - 34 3 
4 - 38 3 
8 - 38 4 
16 - 49 6 
25 0.4 - - 
32 - 52 7 
50 0.4 - - 
64 - 62 7 
100 0.3 - - 
128 - 76 6 
” All assays included 25 mM P-mercaptoethanol. 
h Enzyme activity expressed in nmole/hr/mg. 
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TABLE 7 
EFFECT OF P-MERCAPTOETHANOI ON Nut I rosmt. KI>GI EUYMF~ 
- 
Adenosine kinase’ Deouyadenoaine kinaw 
(5Mercaptoethanol No KC:1 NO Kc‘1 
(rnbf) addition (Xl rnbll addition 10 mhf) 
0 32 56 il !I 
2 32 h 0 4.4 
3 36 ho (1 Y.0 
x 35 70 il x.1 
I6 39 7, - (I Y.X 
32 40 x2 (I Ii.’ 
64 11 80 0 !  2,’ 
13 49 YY 0 10.7 
Notr. Enzyme activity expressed in nmoleihr/mg. 
ciencies associated with the accumulation of nucleosides ( I ,2) and to the 
phosphorylation of potent nucleoside analogs with specific pharmacological 
properties. The easy availability of high specific activity isotopes and 
the use of ion exchange paper (3) provide a simple and rapid measure 
of these activities. 
Previous investigators have noted the necessity of inhibiting deaminase 
enzymes to preserve the nucleoside substrate during assay (9-15). Indeed, 
our observations indicate that if this is not done in placental supernatant, 
then over 50% of deoxyadenosine or over 90% of deoxycytidine is degraded 
by deamination and phosphorolysis (Fig. 1). A valid assay can be achieved. 
if adenosine deaminase or cytidine deaminase is inhibited. However. it 
remains critical to make a definitive identification of the nucleoside kinase 
product at the time the assay is established. This assures that the anion 
exchange paper will bind an established nucleotide product and not an 
artifact. 
Our data suggest other important considerations related to nucleoside 
kinase assays. Uniformly labeled nucleosides should be avoided in kinase 
assays (6-8), as a result of the potential production of labeled ribose-l- 
phosphate or deoxyribose-l-phosphate. These compounds behave like 
nucleotides in chromatography systems and on anion exchange paper. 
We have also found that GTP doubles the assayable deoxyadenosine and 
adenosine kinase in crude placental cytosol. The mechanism for the 
increased activity of deoxyadenosine kinase is related to the production 
of an inhibitory concentration of adenosine from ATP in crude tissue 
extracts. In contrast, GTP is the preferred phosphate donor for adenosine 
kinase not only in crude extracts but even when this enzyme has been 
highly purified (22,25,26). In addition, potassium was an essential cofactor 
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for deoxyadenosine kinase, an activator of adenosine kinase, and inert 
for deoxycytidine kinase. Finally, a sulfhydryl reducing reagent was 
absolutely required for the measurement of deoxycytidine and deoxy- 
adenosine kinase. 
Using the modified conditions described in our experiments, assays 
of adenosine kinase, deoxyadenosine kinase, and deoxycytidine kinase 
are linear with time and protein. The current approach has proven useful 
to one of our colleagues, who was able to achieve linear nucleoside 
kinase assays in extracts from cultured human B lymphoblasts and T 
lymphoblasts after previous difficulties in achieving a valid assay (27). 
SUMMARY 
The measurements of deoxyadenosine kinase, adenosine kinase, and 
deoxycytidine kinase were examined in human placental cytosol to achieve 
a valid and reliable assay linear with time and protein. Our studies confirm 
the need to inhibit deaminase enzymes, since deoxyadenosine and de- 
oxycytidine undergo extensive deamination and phosphorolysis. The use 
of a uniformly labeled nucleoside substrate introduced an artifact because 
the chromatographic behavior of the deoxyribose-l-phosphate, formed 
during the assay, was difficult to distinguish from the deoxynucleoside 
phosphate product. Accurate product identification was also essential. 
Finally, the substitution of GTP in place of ATP as the phosphate donor, 
the addition of a sulfhydryl reducing agent and a monovalent cation need 
to be considered when an assay is optimized. 
The use of these methods have lead to valid assays in placental cytosol 
that are linear with time and protein. Consideration of these important 
principles are necessary when establishing a valid and reliable nucleoside 
kinase assay in a crude tissue preparation. 
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